From a contemporary clinical perspective, these findings also align with the recently proposed cardiovascularkidneymetabolic (CKM) syndrome framework, which emphasizes the interconnected pathophysiology of metabolic dysfunction, CV disease, and kidney disease across a continuum of risk
Some women notice reduced appetite and better energy levels within the first few weeks, while improvements in weight and mood may take a few months
Treatment is 10 mg daily for 10 days, followed by 10 mg monthly for life
It is available as a supplement and can be beneficial in specific cases, but its essential to consult a healthcare professional before taking any supplements
Glucagon and GLP- 1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial